Cargando…
Prominin 2 decreases cisplatin sensitivity in non-small cell lung cancer and is modulated by CTCC binding factor
BACKGROUND: Non-small cell lung cancer (NSCLC) is the major pathological type of lung cancer and accounts for the majority of lung cancer-related deaths worldwide. We investigated the molecular mechanism of prominin 2 (PROM2) involved in cisplatin resistance in NSCLC. PATIENTS AND METHODS: The GEO d...
Autores principales: | Tang, Jiyang, Shu, Dejun, Fang, Zhimin, Yang, Gaolan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476904/ https://www.ncbi.nlm.nih.gov/pubmed/37665741 http://dx.doi.org/10.2478/raon-2023-0033 |
Ejemplares similares
-
Prominin‐1 expression in the testis/epididymis and fertility
por: Fargeas, Christine A., et al.
Publicado: (2023) -
Mouse Tissues Express Multiple Splice Variants of Prominin-1
por: Kemper, Kristel, et al.
Publicado: (2010) -
Targeting prominin2 transcription to overcome ferroptosis resistance in cancer
por: Brown, Caitlin W, et al.
Publicado: (2021) -
Cholesterol regulates plasma membrane bending by prominin-family proteins
por: Bell, Tristan A., et al.
Publicado: (2023) -
Exosomes: Decreased Sensitivity of Lung Cancer A549 Cells to Cisplatin
por: Xiao, Xia, et al.
Publicado: (2014)